Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Suppression of Tumorigenicity 14 (Colon Carcinoma) Antibodies

(Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14))

Your search for reliable ST14 antibodies ends here. ST14, known by aliases such as ST14, st14.L, St14, st14a, st14b, st14.S, is an integral part of our antibody range. Whether you're working with Human, Mouse, Rat, Cow, Guinea Pig, or other species, our range of ST14 antibodies offer precise detection across diverse samples. These specialized antibodies are tailored for various scientific applications like WB, ELISA, IHC, IF, IHC (p), providing you with options like polyclonal, recombinant, and monoclonal antibodies, sourced from different host species such as Rabbit, Mouse, Sheep. The efficacy of our antibodies is well-established, demonstrated through multiple methods.

Detailed information, including references, images, and validations by other customers, can be found on each product page. Should you require assistance in finding a specific product, our customer service team is ready to assist. Utilize our ST14 antibodies in your research endeavors for dependable ST14 detection.

ST14 antibody  (AA 11-100) ST14 antibody  (AA 11-100) ST14 antibody (AA 11-100) (ABIN669726)

ST14 Reactivity: Human WB, ELISA, IHC (p), IF (cc), IF (p), IHC (fro) Host: Rabbit Polyclonal unconjugated

ST14 antibody  (Internal Region) ST14 antibody  (Internal Region) ST14 antibody (Internal Region) (ABIN6263143)

ST14 Reactivity: Human, Mouse WB, ELISA, IHC, IF, ICC Host: Rabbit Polyclonal unconjugated

ST14 antibody  (C-Term) ST14 antibody  (C-Term) ST14 antibody (C-Term) (ABIN652185)

ST14 Reactivity: Human, Mouse WB, IHC (p) Host: Rabbit Polyclonal RB2080 unconjugated

Suppression of Tumorigenicity 14 (Colon Carcinoma) Antibodies by Reactivity

Find Suppression of Tumorigenicity 14 (Colon Carcinoma) Antibodies for a variety of species such as anti-Human Suppression of Tumorigenicity 14 (Colon Carcinoma), anti-Mouse Suppression of Tumorigenicity 14 (Colon Carcinoma), anti-Rat Suppression of Tumorigenicity 14 (Colon Carcinoma). The species listed below are among those available. Click on a link to go to the corresponding products.

Suppression of Tumorigenicity 14 (Colon Carcinoma) Antibodies by Application

Find Suppression of Tumorigenicity 14 (Colon Carcinoma) Antibodies validated for a specific application such as WB, ELISA, IHC, IF. Some of the available applications are listed below. Click on a link to go to the corresponding products.

Suppression of Tumorigenicity 14 (Colon Carcinoma) Antibodies by Host

Find Suppression of Tumorigenicity 14 (Colon Carcinoma) Antibodies with a specific Host. The Host listed below are among those available. Click on a link to go to the corresponding products.

Suppression of Tumorigenicity 14 (Colon Carcinoma) Antibodies by Binding Specificity

Find Suppression of Tumorigenicity 14 (Colon Carcinoma) Antibodies with a specific epitope. The epitopes listed below are among those available. Click on a link to go to the corresponding products.

Suppression of Tumorigenicity 14 (Colon Carcinoma) Antibodies by Clonality

Find available monoclonal or polyclonal Suppression of Tumorigenicity 14 (Colon Carcinoma) Antibodies. Click on a link to go to the corresponding products.

Suppression of Tumorigenicity 14 (Colon Carcinoma) Antibodies by Clone

Find Suppression of Tumorigenicity 14 (Colon Carcinoma) Antibodies with a specific Clone. The Clone listed below are among those available. Click on a link to go to the corresponding products.

Suppression of Tumorigenicity 14 (Colon Carcinoma) Antibodies by Conjugate

Find Suppression of Tumorigenicity 14 (Colon Carcinoma) Antibodies with a specific conjugate such as Biotin, FITC, APC. The conjugates listed below are among those available. Click on a link to go to the corresponding products.

Popular Suppression of Tumorigenicity 14 (Colon Carcinoma) Antibodies

Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity Human
Application WB, ELISA, IHC (p), IF (cc), IF (p), IHC (fro)
Validations
  • (4)
Cat. No. ABIN669726
Quantity 100 μL
Datasheet Datasheet
Reactivity Human, Mouse
Application WB, ELISA, IHC, IF, ICC
Validations
  • (3)
Cat. No. ABIN6263143
Quantity 100 μL
Datasheet Datasheet
Reactivity Human, Mouse
Application WB, IHC (p)
Validations
  • (3)
Cat. No. ABIN652185
Quantity 400 μL
Datasheet Datasheet
Reactivity Human, Mouse, Rat
Application WB, IHC
Validations
  • (3)
Cat. No. ABIN632186
Quantity 100 μL
Datasheet Datasheet
Reactivity Cow, Dog, Guinea Pig, Horse, Human, Mouse, Pig, Rabbit, Rat
Application WB, IHC
Validations
  • (1)
  • (3)
Cat. No. ABIN2773910
Quantity 100 μL
Datasheet Datasheet
Reactivity Human
Application WB, IF, IHC (p), EIA
Validations
  • (4)
Cat. No. ABIN615862
Quantity 50 μg
Datasheet Datasheet
Reactivity Human, Mouse
Application ELISA, IHC
Validations
  • (2)
Cat. No. ABIN7235293
Quantity 200 μL
Datasheet Datasheet
Reactivity Human
Application WB, ELISA, IHC, IF, IHC (p)
Validations
  • (2)
Cat. No. ABIN2878727
Quantity 50 μL
Datasheet Datasheet
Reactivity Human
Application ELISA
Validations
  • (1)
  • (1)
Cat. No. ABIN520529
Quantity 100 μg
Datasheet Datasheet
Reactivity Human
Application WB, ELISA, IF
Validations
  • (1)
Cat. No. ABIN7188865
Quantity 100 μg
Datasheet Datasheet
Reactivity Human
Application ELISA, IHC
Validations
  • (1)
Cat. No. ABIN7171018
Quantity 100 μL
Datasheet Datasheet
Reactivity Human
Application WB, ELISA
Validations
  • (1)
Cat. No. ABIN563019
Quantity 50 μL
Datasheet Datasheet
Reactivity Cow, Guinea Pig, Horse, Human, Rat
Application WB
Validations
  • (1)
Cat. No. ABIN6744844
Quantity 100 μL
Datasheet Datasheet
Reactivity Human
Application WB
Validations
  • (1)
Cat. No. ABIN6148517
Quantity 100 μL
Datasheet Datasheet
Reactivity Human
Application WB, ELISA, IF
Validations
  • (2)
Cat. No. ABIN1534221
Quantity 100 μL
Datasheet Datasheet

Latest Publications for our Suppression of Tumorigenicity 14 (Colon Carcinoma) Antibodies

Landova Sulcova, Zahradnicek, Dumkova, Dosedelova, Krivanek, Hampl, Kavkova, Zikmund, Gregorovicova, Sedmera, Kaiser, Tucker, Buchtova: "Developmental mechanisms driving complex tooth shape in reptiles." in: Developmental dynamics : an official publication of the American Association of Anatomists, Vol. 249, Issue 4, pp. 441-464, (2020) (PubMed).

Drees, Königsmann, Jaspers, Pflanz, Riedel, Schuh: "Conserved function of the matriptase-prostasin proteolytic cascade during epithelial morphogenesis." in: PLoS genetics, Vol. 15, Issue 1, pp. e1007882, (2019) (PubMed).

Buzza, Johnson, Conway, Martin, Mukhopadhyay, Shea-Donohue, Antalis: "Inflammatory cytokines down-regulate the barrier-protective prostasin-matriptase proteolytic cascade early in experimental colitis." in: The Journal of biological chemistry, Vol. 292, Issue 26, pp. 10801-10812, (2017) (PubMed).

Friis, Tadeo, Le-Gall, Jürgensen, Sales, Camerer, Bugge: "Matriptase zymogen supports epithelial development, homeostasis and regeneration." in: BMC biology, Vol. 15, Issue 1, pp. 46, (2017) (PubMed).

Friis, Madsen, Bugge: "Distinct Developmental Functions of Prostasin (CAP1/PRSS8) Zymogen and Activated Prostasin." in: The Journal of biological chemistry, Vol. 291, Issue 6, pp. 2577-82, (2016) (PubMed).

Zoratti, Tanabe, Varela, Murray, Bergum, Colombo, Lang, Molinolo, Leduc, Marsault, Boerner, List: "Targeting matriptase in breast cancer abrogates tumour progression via impairment of stromal-epithelial growth factor signalling." in: Nature communications, Vol. 6, pp. 6776, (2015) (PubMed).

Sales, Friis, Abusleme, Moutsopoulos, Bugge: "Matriptase promotes inflammatory cell accumulation and progression of established epidermal tumors." in: Oncogene, Vol. 34, Issue 35, pp. 4664-72, (2015) (PubMed).

Hwang, Kim, Min, Raghunathan, Panova, Munshi, Ryu: "Epigenetic Silencing of SPINT2 Promotes Cancer Cell Motility via HGF-MET Pathway Activation in Melanoma." in: The Journal of investigative dermatology, Vol. 135, Issue 9, pp. 2283-91, (2015) (PubMed).

Szabo, Peters, Kosa, Camerer, Bugge: "Regulation of feto-maternal barrier by matriptase- and PAR-2-mediated signaling is required for placental morphogenesis and mouse embryonic survival." in: PLoS genetics, Vol. 10, Issue 7, pp. e1004470, (2015) (PubMed).

Beaulieu, Gravel, Cloutier, Marois, Colombo, Désilets, Verreault, Leduc, Marsault, Richter: "Matriptase proteolytically activates influenza virus and promotes multicycle replication in the human airway epithelium." in: Journal of virology, Vol. 87, Issue 8, pp. 4237-51, (2013) (PubMed).

Aliases for Suppression of Tumorigenicity 14 (Colon Carcinoma) Antibodies

suppression of tumorigenicity 14 (ST14) Antibodies
suppression of tumorigenicity 14 L homeolog (st14.L) Antibodies
suppression of tumorigenicity 14 (colon carcinoma) (St14) Antibodies
suppression of tumorigenicity 14 (St14) Antibodies
suppression of tumorigenicity 14 (colon carcinoma) a (st14a) Antibodies
suppression of tumorigenicity 14 (colon carcinoma) b (st14b) Antibodies
suppression of tumorigenicity 14 S homeolog (st14.S) Antibodies
Epithin Antibodies
HAI Antibodies
hai Antibodies
matriptase Antibodies
mCAP3 Antibodies
MT-SP1 Antibodies
mt-sp1 Antibodies
MTSP1 Antibodies
mtsp1 Antibodies
PRSS14 Antibodies
prss14 Antibodies
Prss14 Antibodies
SNC19 Antibodies
snc19 Antibodies
st14 Antibodies
st14-a Antibodies
st14-b Antibodies
st14a Antibodies
st14b Antibodies
TADG15 Antibodies
tadg15 Antibodies
tmprss1 Antibodies
TMPRSS14 Antibodies
Tmprss14 Antibodies
wu:fi41g07 Antibodies
wu:fl72f01 Antibodies
XMT-SP1 Antibodies
zgc:136950 Antibodies
zgc:152656 Antibodies
zgc:152657 Antibodies
zgc:152947 Antibodies
You are here:
Support